A Single-Dose Pharmacokinetics Study of Tapimycin Injection
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the pharmacokinetic properties of Tapimycin injection
(piperacillin 4 g + tazobactam 0.5 g powder for injection) in healthy volunteers under
fasting conditions.